Purpose: Up to 50% of Asian patients with NSCLC have EGFR gene mutations, indicating that selecting eligible patients for EGFR-TKIs treatments is clinically important. The aim of the study is to develop and validate radiomics-based nomograms, integrating radiomics, CT features and clinical characteristics, to non-invasively predict EGFR mutation status and subtypes. Materials and Methods: We included 637 patients with lung adenocarcinomas, who performed the EGFR mutations analysis in the current study. The whole dataset was randomly split into a training dataset (n = 322) and validation dataset (n = 315). A sub-dataset of EGFR-mutant lesions (EGFR mutation in exon 19 and in exon 21) was used to explore the capability of radiomic features for predicting EGFR mutation subtypes. Four hundred seventy-five radiomic features were extracted and a radiomics sore (R-score) was constructed by using the least absolute shrinkage and selection operator (LASSO) regression in the training dataset. A radiomics-based nomogram, incorporating clinical characteristics, CT features and R-score was developed in the training dataset and evaluated in the validation dataset. Results: The constructed R-scores achieved promising performance on predicting EGFR mutation status and subtypes, with AUCs of 0.694 and 0.708 in two validation datasets, respectively. Moreover, the constructed radiomics-based nomograms excelled the R-scores, clinical, CT features alone in terms of predicting EGFR mutation status and subtypes, with AUCs of 0.734 and 0.757 in two validation datasets, respectively. Conclusions: Radiomics-based nomogram, incorporating clinical characteristics, CT features and radiomic features, can non-invasively and efficiently predict the EGFR mutation status and thus potentially fulfill the ultimate purpose of precision medicine. The methodology is a possible promising strategy to predict EGFR mutation subtypes, providing the support of clinical treatment scenario.
Keywords: CT; EGFR; lung adenocarcinomas; nomogram; radiomics.
Copyright © 2020 Zhao, Wu, Xu, Sun, Gao, Tan, Ma, Li, Jin, Hua, Liu and Li.
Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer.Eur J Nucl Med Mol Imaging. 2020 May;47(5):1137-1146. doi: 10.1007/s00259-019-04592-1. Epub 2019 Nov 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31728587
[Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].Zhonghua Zhong Liu Za Zhi. 2019 Apr 23;41(4):282-287. doi: 10.3760/cma.j.issn.0253-3766.2019.04.007. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31014053 Chinese.
A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.Phys Med Biol. 2020 Mar 6;65(5):055012. doi: 10.1088/1361-6560/ab6f98. Phys Med Biol. 2020. PMID: 31978901
PET/CT radiomics in breast cancer: Mind the step.Methods. 2020 Jan 21:S1046-2023(19)30263-4. doi: 10.1016/j.ymeth.2020.01.007. Online ahead of print. Methods. 2020. PMID: 31978538 Review.
Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions.Korean J Radiol. 2020 Feb;21(2):159-171. doi: 10.3348/kjr.2019.0630. Korean J Radiol. 2020. PMID: 31997591 Free PMC article. Review.